NCT06468761

Brief Summary

This was a retrospective study conducted in three Nursing Homes (NHs). Residents who had survived the 1st CoPW (March to May 2020) were included. The diagnosis of COVID-19 was based on the results of a positive reverse transcriptase-polymerase chain reaction test. The collected data also included age, sex, length of residence in the NH, disability status, legal guardianship status, nutritional status, need for texture-modified food, hospitalization or Emergency Department visits during lockdown and SARS-COV2 vaccination status during the follow-up. Non-adjusted and adjusted Cox models were used to analyse factors associated with 2-year post-1stCoPW mortality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
315

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 11, 2020

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 25, 2022

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 26, 2022

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

June 18, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 21, 2024

Completed
Last Updated

June 21, 2024

Status Verified

June 1, 2024

Enrollment Period

2.2 years

First QC Date

June 18, 2024

Last Update Submit

June 18, 2024

Conditions

Keywords

COVID-19Older AdultsNursing homeLong-tem mortality

Outcome Measures

Primary Outcomes (1)

  • All cause mortality

    months

Eligibility Criteria

Age70 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

315 residents of 3 nursibg omes, mean age 86 years old. 50% severe disability. 111 contracted COVID-19 and survived the first pandemic wave.

You may qualify if:

  • Living in one of the Nursing Homes during the fiorst COVID-19 pandemic wave
  • Having survived the first pandemic wave

You may not qualify if:

  • Residents who died during the first pandemic wave
  • Refusal for articipation to the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Geriatrics

Paris, 75018, France

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Md PhD

Study Record Dates

First Submitted

June 18, 2024

First Posted

June 21, 2024

Study Start

May 11, 2020

Primary Completion

July 25, 2022

Study Completion

July 26, 2022

Last Updated

June 21, 2024

Record last verified: 2024-06

Locations